Responses
Other content recommended for you
- Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy
- Neuropathology and emerging biomarkers in corticobasal syndrome
- Genetics of Parkinson’s disease and related disorders
- Beyond and below the cortex: the contribution of striatal dysfunction to cognition and behaviour in neurodegeneration
- Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism
- Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy
- Midcingulate involvement in progressive supranuclear palsy and tau positive frontotemporal dementia
- Survival in progressive supranuclear palsy and frontotemporal dementia
- An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology
- Stiff person syndrome